Gregory D Perry insider trades

Open-market stock purchases and sales by Gregory D Perry, Chief Financial Officer & PFO at Merus NV, from SEC Form 4 filings since Jul 23, 2010.

Recent trades

DateStockTradeValue
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—

Companies traded

  • MRUS Merus NV: other filings, last Dec 12, 2025
  • KALA KALA BIO, Inc: other filings, last Jun 15, 2025
  • FNCH Finch Therapeutics Group, Inc: other filings, last Feb 25, 2022
  • NVLN Novelion Therapeutics Inc: other filings, last May 9, 2017
  • AEGR Aegerion Pharmaceuticals, Inc: other filings, last Nov 29, 2016
  • OCAT Ocata Therapeutics, Inc: other filings, last Feb 10, 2016
  • EBIO Eleven Biotherapeutics, Inc: other filings, last Feb 26, 2015
  • ACTC Advanced Cell Technology, Inc: other filings, last Sep 30, 2014
  • NVIV Invivo Therapeutics Holdings Corp: other filings, last Dec 30, 2013
  • IMGN Immunogen Inc: 7 sales, last Sep 10, 2013

Get free alerts when Gregory D Perry files a new trade →